Magnesium sulfate (MgSO 4 ) ameliorates focal ischemia-induced neuronal death in the rat and gerbil models. However, the molecular mechanisms for this neuroprotection are not known. Focal cerebral ischemia was produced by unilateral occlusion of the right common carotid artery and the right middle cerebral artery (CCAO + MCAO) for 30 min or 60 min. Treatment with MgSO 4 significantly increased the level of mitogen-activated protein kinase/extra-cellular signal-regulated kinase kinase 1/ 2 (MEK1/2), extra-cellular signal-regulated kinase 1/2 (ERK1/2), cyclic-AMP response element binding protein (CREB) phosphorylation and the anti-apoptotic protein Bcl-2 both in the non-ischemic (contralateral) and ischemic (ipsilateral) cortex. However, these effects were reversed by administration of U0126, a MEK kinase inhibitor. In the ipsilateral cortex, a significant increase in the level of the proapoptotic proteins Bax, Bad, BNIP3 and activated caspase 3 were detected at the end of focal ischemia compared to the non-ischemic cortex. Treatment of MgSO 4 prevented these ischemia-induced activations of the death cascade. Collectively, these data indicate that the ERK-CREB-Bcl-2 signaling pathway might be involved in MgSO 4 -induced neuroprotection following focal ischemia. Moreover, MgSO 4 treatment also resulted in a reduction in pro-apoptotic proteins. These results enhance our understanding on the role of MgSO 4 in treating cerebral ischemia.
Introduction
Magnesium (Mg 2+ ) is widely recognized for its importance in a wide variety of critical cellular processes including oxidative phosphorylation, glycolysis, cellular respiration and protein synthesis (6) . The serum level of ionized Mg 2+ was lower than the normal level in patients shortly after a stroke (3) . Ischemia brain injury also decreased Mg 2+ concentration in the rat brain (36) . Moreover, treatment with exogenous Mg 2+ has been shown to reduce the infarction volume (17) , regional cerebral edema, injury-related motor and cognitive dysfunction (22) . MgSO 4 treatment improved early functional scores after mechanical injury to the spinal cord (8) . However, the molecular mechanisms by which MgSO 4 intervenes in focal ischemia-induced apoptotic cell death are unclear. In the vascular smooth muscle cells, Mg 2+ activates ERK/MAPK (34), a wellcharacterized intracellular signaling cascade implicated in cellular growth and survival (37) .
In both in vivo and in vitro ischemia models, extra-cellular signal-regulated kinase (ERK), a member of the mitogen-activated protein kinase (MAPKs) family, has been demonstrated to be involved in regulating brain cell death and survival after ischemia (11, 24) . Activation of ERK signaling pathway was linked to neuroprotection in ischemic tolerance and in estradiol protection of CA1 neurons in global ischemia (12, 32) . The ERK signaling pathway activates and phosphorylates nuclear transcription factors such as the cAMP-response element binding protein (CREB) which regulates target genes important in neuronal survival and protection. CREB regulates genes that mediate neuronal survival including the brain-derived neurotrophic factor and the antiapoptotic protein Bcl-2 (13) .
Activation of the mitochondria-dependent apoptotic signaling pathway plays a crucial role in ischemic neuronal cell death (20) . Since the Bcl-2 family proteins act upstream of the cellular damage and focus their effects at the mitochondria, Bcl-2 family proteins is likely to play an essential role (23) . Commitment to apoptosis is typically governed by opposing factions of the Bcl-2 family including proapoptotic as opposed to anti-apoptotic family members (20) . Pro-apoptotic and anti-apoptotic Bcl-2 family members can homo-or heterodimerize and neutralize each other so that the relative balance of these effectors strongly influences cell fate (23) . Bcl-2, an antiapoptotic protein, prevents cytochrome c release, whereas the pro-apoptotic proteins Bax, Bad and BNIP3 enhance cytochrome c release from the mitochondria. Bad has been reported to play a critical role in the regulation of cell death in cerebral ischemia (23, 40) . When cytochrome c is released from the mitochondria into the cytosol, it is responsible for activating caspase-9 which further activates caspase-3, a principal effector caspase of apoptosis, and executes the apoptotic program (23) .
Many models have been developed to study focal cerebral ischemia in different animal species. Increasing interests have been shown for developing a reliable focal ischemia model in Mongolian gerbils (4) . This animal species lacks the connection between carotid and vertebrobasilar circulation which makes the circle of Willis incomplete resulting in less collateral blood supply to the gerbil's brain. Each hemisphere seems to have an independent blood supply. In this study, unilateral occlusion of the right common carotid artery (CCAO) and the right middle cerebral artery (MCAO) was used to induce focal cerebral ischemia in the right cortex of the gerbils. The results obtained on the ipsilateral (ischemic) and contralateral (non-ischemic) sides from one gerbil could be compared and contrasted (17) . Changes in the ERK signaling cascade and mitochondrial apoptogenic proteins in the ipsilateral and contralateral cortexes of these gerbils were measured simultaneously during ischemia, with or without MgSO 4 pre-treatment. This study showed that pre-treatment with the MEK inhibitor U0126 reduced Bcl-2 upregulation observed in response to MgSO 4 treatment in the ipsilateral cortex 60 min after the onset of ischemia. Moreover, pro-apoptotic proteins were decreased in MgSO 4 treatment groups.
Materials and Methods

Induction of Focal Cerebral Ischemia
Male gerbils (65-85 g) were obtained from the Laboratory Animal Center at Taichung Veterans General Hospital (Taichung, Taiwan). These animals were allowed to acclimate to their environmentally controlled quarters (25°C and 12 h : 12 h light-dark cycle) before the experiments. All protocols were approved by the Institutional Animal Care and Use Committee of Central Taiwan University of Science and Technology, Taichung, Taiwan, and the principles of laboratory animal care (NIH publications) were followed.
The gerbil was anesthetized with chlorohydrate (400 mg/kg, i.p.) and its body temperature was maintained at 37°C with a heating pad (CMA/150). A midline neck incision was made and the right carotid artery was exposed and separated from the vagosympathetic trunks. The right carotid artery was loosely encircled with a 4-O suture for later occlusion. The gerbil's head was placed in a stereotaxic frame (David Kopf, CA, USA) with the nose bar positioned 4.0 mm below the horizontal line. Following a midline 
U0126 Intracerebroventricular (icv) Administration
Chlorohydrate-anesthetized gerbils were injected with the MEK inhibitor U0I26 (5 µl 100 µM, in 3% dimethyl sulfoxide) or vehicle (3% dimethyl sulfoxide) at a flow rate of 5 µl/min into the right lateral ventricle 45 min before the onset of CCAO + MCAO. The gerbil's head was placed in a stereotaxic frame with the nose bar positioned 4.0 mm below the horizontal line. A stainless steel cannula (26 gauge) was stereotaxically implanted into the right lateral ventricle (AP-1.3 mm, ML + 2.0 mm, and DL-2.5 mm from bregma).
Western Blotting
Cortex or hippocampus was homogenized in ice-cold lysis buffer for 1 min. The homogenates were centrifuged at 12,000 g for 40 min twice. The supernatant was collected and stored at -70°C for further experiments. Protein concentration of tissue extract was determined using the Bradford method (Bio-Rad Protein Assay, Hercules, CA, USA). Protein homogenates were separated on a 10% SDS-PAGE with a constant voltage of 75 V. Electrophoresed proteins were transferred to 0.45 µm polyvinylidene difluoride (PVDF) membrane (Millipore, Bedford, MA, USA) with a transfer apparatus (Bio-Rad, Hercules, CA, USA). The PVDF membranes were incubated in 5% non-fat milk in TBS buffer at room temperature for 1 h. Primary antibodies against pMEK1/2, pERK1, pERK2, CREB, pCREB, Bcl-2, Bax, Bad, BNIP3, caspase 3 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and α-tubulin (Neo Markers, Fremont, CA, USA) were diluted in an antibody binding buffer overnight at 4°C. The blots were washed 3 times in TBS buffer for 10 min and then immersed in the second antibody solution containing goat anti-mouse IgG-HRP or goat anti-rabbit IgG-HRP (Santa Cruz) antibodies for 2 h and diluted in TBS buffer. The membranes were washed 3 times for 10 min in TBS buffer. The immunoblotted proteins were visualized using an ECL Western blotting luminal reagent and quantified using a Fujifilm LAS-3000 chemiluminescence detection system (Tokyo, Japan).
Statistical Analysis
The protein levels were compared using oneway ANOVA with preplanned contrast comparison. In all cases, P < 0.05 was considered significant.
Results
MgSO 4 -induced ERK Phosphorylation During Focal Ischemia in Gerbil Cortex
To investigate the effects of ischemia and MgSO 4 on ERK activity, we subjected gerbils that had been treated with MgSO 4 or saline 30 min before CCAO + MCAO occlusion to examination of pMEK1/2, pERK1 and pERK2 protein levels in the ipsilateral and contralateral cortex at the end of ischemia. Focal cerebral ischemia increased the pMEK1/2 and pERK1 levels in the ischemic (ipsilateral) cortex as compared with non-ischemic (contralateral) cortex at the end of ischemia (Figs. 1a and 1b). Using these focal ischemic models by 30 or 60 min CCAO + MCAO, MgSO 4 significantly increased MEK1/2, ERK1/2 phosphorylation both in non-ischemic cortex (60 min ischemia: pMEK1/2 increased to 2.2-fold, P < 0.01; pERK1 increased to 33-fold, P < 0.01; pERK2 increased to 6.5-fold, Fig. 1b ) and in ischemic cortex (60 min ischemia: pMEK1/2 increased to 3.3-fold, P < 0.01; pERK1 increased to 8.5-fold, P < 0.01; pERK2 increased to 9.2-fold P < 0.01, Fig. 1b) , as compared with salinetreated gerbils. These findings indicated that focal ischemia induced MEK and ERK1/2 phosphorylation during the ischemic period in the gerbil cortex. MgSO 4 administration dramatically induced a marked increases the phosphorylation of MEK1/2 and ERK1/2 in the gerbil cortex in the presence or absence of ischemia. 
MgSO 4 -induced CREB Phosphorylation and Bcl-2 Protein Expression During Focal Ischemia in Gerbil Cortex
A well-characterized downstream target of MAPK/ERK is the transcription factor CREB which promotes transcription of several genes. Bcl-2 gene is one of the downstream targets of CREB, and Bcl-2 is an antiapoptotic factor implicated in the preservation of integrity of the mitochondrial outer membrane. To examine whether MgSO 4 regulates CREB phosphorylation and Bcl-2 protein expression, we subjected MgSO 4 or saline-treated gerbils 30 min before CCAO + MCAO to examination of changes in CREB, pCREB and Bcl-2 in ipsilateral and contralateral cortex at the end of ischemia. Thirty minutes of CCAO + MCAO did not affect CREB phosphorylation. Sixty minutes of CCAO + MCAO induced a decrease in pCREB (reduction to 40%, P < 0.05) at the end of ischemia as compared with non-ischemic cortex, respectively (Fig. 2b) . MgSO 4 exposure significantly increased CREB phosphorylation in non-ischemic (increased to 1.8-fold, P < 0.01) and ischemic cortex (increased to 5-fold, P < 0.01). Incidentally, MgSO 4 prevented the 60 min ischemia-induced CREB dephosphorylation (Fig. 2b) . Focal ischemia induced an increase in Bcl-2 expression in gerbil cortex at the end of ischemia (60 min ischemia, increased to 2.6-fold, P < 0.01, Fig. 2b ). MgSO 4 exposure significantly increased the expression of Bcl-2 proteins in nonischemic (60 min ischemia, increased to 4.4-fold, P < 0.01, Fig. 2b ) and ischemic cortex (30 min ischemia, increased to 1.8-fold, P < 0.05; 60 min ischemia, magnesium sulfate maintained the high level of Bcl-2) as compared with saline-treated gerbils.
ERK Signaling Is Critical to MgSO 4 -Induced CREB Phosphorylation and Bcl-2 Protein Expression
To examine if the MEK/ERK signaling pathway is involved in the MgSO 4 ability to maintain CREB phosphorylation and Bcl-2 protein expression, a MEK inhibitor U0126, or vehicle, was administered into the right lateral ventricle 45 min before ischemia. As shown in Fig. 3 , U0126 administration blocked the MgSO 4 -induced phosphorylation increase in MEK1/ 2, ERK1/2 and CREB and the expression of Bcl-2 proteins in the ischemic (ipsilateral) cortex of gerbils. These results demonstrated that U0126 effectively infused into the right ventricles and inhibited its The pMEK1/2, pERK1, pERK2, pCREB and Bcl-2 protein products extracted from the ipsilateral cortex at the end of 60 min right CCAO + MCAO in the 2 saline-treated, 2 magnesium sulfate-treated couple with received vehicle icv, and 2 magnesium sulfate-treated couple with received U0126 icv gerbils were measured by Western blots. B: Bars represent the relative proteins quantification of pMEK1/2, pERK1, pERK2, pCREB and Bcl-2 on the basis of α-tubulin and indicate mean values ± SD (n = 6 in each group). *P < 0.05; **P < 0.01.
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target MEK1/2. These findings suggest a critical role for ERK signaling in the ability of MgSO 4 to maintain CREB phosphorylation and to activate Bcl-2 protein expression.
MgSO 4 Prevents the Expression of Apoptotic Protein Signaling at the Focal Ischemia in Gerbil Cortex
The proapoptotic proteins Bax, Bad and BNIP3 promote ischemic cell death by inducing the release of apoptogenic factors (1, 10, 40) . In this study, we examined the effect of MgSO 4 exposure effect on the expression of the Bax, Bad and BNIP3 proteins that could potentially contribute to mitochondrial apoptosis signaling after ischemia. We subjected MgSO 4 or saline-treated gerbils for 30 min before CCAO + MCAO occlusion to analysis of the Bax, Bad and BNIP3 proteins in the ipsilateral and contralateral cortex at the end of ischemia. As shown in Fig. 4 , 60 min ischemia significantly upregulated the expression of Bax, Bad and BNIP3 proteins in the ischemic (ipsilateral) cortex when compared with non-ischemic (contralateral) cortex. MgSO 4 exposure significantly prevented ischemia-induced Bax, Bad and BNIP3 proteins in the ischemic cortex. In contrast, MgSO 4 exposure did not affect the expression of Bax and Bad proteins in the non-ischemic cortex. MgSO 4 also induced Bcl-2 protein expression in the ischemic cortex. These results suggest that MgSO 4 administration in the ischemic cortex could result in a shift in the balance between anti-and pro-apoptotic proteins in favor of promoting cell survival.
MgSO 4 Prevents the Activation of Caspase-3 Proteins During Focal Ischemia in Gerbil Cortex
The upregulated pro-apoptotic proteins Bax and Bad disrupt mitochondrial membrane integrity during ischemia leading to the release of cytochrome C and the activation of caspase-3, a terminator caspase implicated in the execution step of apoptosis (1, 10, 40) . Sixty-minute focal ischemia induced a 5-fold increase in the activated forms of the caspase 3 protein when compared with non-ischemic (contralateral) cortex. Consistent with the results from other pro-apoptotic proteins, the active caspase 3 (17 kDa) in the ischemic cortex was also significantly reduced by MgSO 4 exposure (Fig. 5) . 
Discussion
It has been shown that MgSO 4 treatment has a neuroprotective effect on reversing focal ischemia in the gerbil model (17) . Here we demonstrated that ERK-dependent CREB phosphorylation and CREBmediated Bcl-2 expression occurred in MgSO 4 -treated gerbils when subjected to focal ischemia. Furthermore, we found that administration of MgSO 4 could prevent ischemia-induced the pro-apoptotic proteins Bax, Bad, BNIP3 and caspase 3 activation.
The role of phosphorylated ERK in neuronal survival or death is controversial. Our study showed that after 30 min or 60 min focal cerebral ischemia in gerbil, the pMEK1/2 and pERK1/2 levels were slightly increased within the cortex. Administration of MgSO 4 significantly upregulated the pERK1/2 signaling pathway during focal ischemia. Furthermore, we found that ERK1/2 activation caused by ischemia alone, or ischemia with MgSO 4 treatment, differentially activated downstream-signaling pathways. ERK1/2 was activated caused by ischemia with MgSO 4 treatment coupled to CREB phosphorylation. In contrast, slight ERK1/2 activation caused by ischemia alone was unable to link with CREB phosphorylation, and might even have reduced the level of CREB phosphorylation in ischemia alone suggesting that other downstream cascades other than CREB phosphorylation might be involved subsequent to ERK activation.
Slight ERK1/2 activation caused by ischemia alone may mediate injury-induced tissue damages. ERK-mediated cell death has been reported in numerous animal models (41) . In a mouse model of stroke induced by transient occlusion of the middle cerebral artery, an increase in phosphorylated ERK in the cortical cells was detected, and pretreatment with the MEK inhibitor PD98059 blocked ERK phosphorylation resulting in a 55% decrease in focal infarct volume at 22 h (2). In a forebrain gerbil model of ischemia induced by bilateral carotid artery occlusion, Namura et al. obtained similar results using another MEK inhibitor U0126 (24) . What are the mechanisms for slight ERK1/2 activation caused by ischemia alone that induced tissue damage? Wang et al. found that ERK1/2 acted upstream of caspase-3 in the brain after ischemia/reperfusion (39) . ERK1/2 may act on mitochondria through Bax and p53. In osteoblastic cells, Bax expression is increased after treatment with H 2 O 2 , and inhibition of the ERK pathway decreased Bax expression (26) . The mechanism by which ERK mediates cell death is mediated via activation of (41) . In our study, we found that ischemia alone induced expression of Bax, Bad and the activation of caspase 3 but not the expression of Bcl-2 and CREB phosphorylation suggesting the presence of caspase death cascades and the absence of the endogenous survival and repair mechanisms. Slight ERK1/2 activation may participate in these signaling pathways but other intracellular signal transduction pathways may also be involved.
In contrast, many studies have shown that ERK activation is a neuroprotective signal (9, 12, 28, 32) . In ischemic animal models, neuroprotective exposures such as hypothermia and preconditioning have been linked to ERK activation (9, 32) . Cho et al. showed that N-acetyl-O-methyldopamine (NAMDA) activated ERK1/2 and protected hippocampal neurons after exposure to in vitro and in vivo ischemia (28) . Furthermore, estradiol, the primary estrogen secreted by the ovary, has been shown to afford neuroprotection by activating ERK in models of global ischemia (12) , quinolinic acid (15) and glutamate excitotoxicity (31), oxidative stress (21) and β-amyloid toxicity (7). In addition, NAMDA-and estrogen-induced neuroprotection via ERK activation also leads to CREB phosphorylation. In this study, we observed that MgSO 4 maintained CREB phosphorylation in the face of ischemia and that U0126 reversed magnesium sulfate-dependent CREB phosphorylation indicating a causal relation between ERK MAPK signaling and CREB activation. Therefore, MgSO 4 -induced neuroprotection via ERK activation leading to CREB phosphorylation may be a key step toward transcription of a CRE-mediated gene that is necessary for survival.
CREB phosphorylation has been linked to neuroprotection in experimental animal stroke models (18, 38) and inhibition of ERK by U0126 reversed the protective effect of CREB following transient global ischemia (28) . Phosphorylation of CREB influences the expression of subsequent CRE-mediated genes including BDNF, c-fos and the antiapoptotic protein Bcl-2. Accumulating evidence indicates that increased Bcl-2 expression provides protection against apoptosis and ischemic insults (14, 19) . Thus, the protective effect of CREB phosphorylation against ischemic neuronal death may be attributable to increased Bcl-2 expression. In the present study, we observed increased Bcl-2 expression 90 min after exposure to MgSO 4 both in ischemic (ipsilateral) cortex and nonischemic (contralateral) cortex sides, the former being inhibited by pretreatment with U0126, suggesting that Bcl-2 expression was induced by ERK MAPK-mediated CREB phosphorylation and might be involved in the neuroprotective role of MgSO 4 after exposure to ischemia.
Many studies have suggested that cerebral ischemia disrupt the functional integrity of the outer mitochondrial membrane releasing cytochrome c and Smac/DIABLO which subsequently activates the caspase death cascades (25, 33) . The Bcl-2 family of proteins includes both pro-apoptotic and anti-apoptotic members and the relative balance of each other strongly influences cell fate (20) . The anti-apoptotic proteins, such as Bcl-2, enhance cell survival after ischemia by preserving mitochondrial membrane integrity (19) . Our findings suggest that MgSO 4 promotes neuronal survival, at least in part, by increasing expression levels of Bcl-2; our data are consistent with the observation that Bcl-2 mediates magnesium neuroprotection in traumatic brain injury models (16) . In contrast, the pro-apoptotic proteins Bax, Bad and Bim promote ischemic cell death by inducing the release of apoptogenic factors from the mitochondria and by activating the caspase death cascades (5, 40) . In the current study, the expression of Bax, Bad and BNIP3 was found to be significantly increased in the ischemic cortex. MgSO 4 treatment significantly decreased these pro-apoptotic protein expression lelves in the ischemic cortex. Our results indicate that MgSO 4 treatment upregulated the antiapoptotic Bcl-2 family proteins (Bcl-2) as well as downregulated the proapoptotic Bcl-2 family proteins (Bax, Bad and BNIP3) in ischemic cortex of gerbils resulting in a shift in the balance between antiapoptotic and proapoptotic effects toward the former. In other words, our findings suggest that MgSO 4 treatment shifted the balance of Bcl-2 family toward antiapoptotic effects in ischemic cortex of gerbils. Similar findings were observed in cortical neurons of newborn piglets in which hypoxia decreased the Bcl-2/Bax ratio while MgSO 4 treatment increased it (29) .
Shifting the balance of the Bcl-2 family proteins toward antiapoptotic effects blocks the release of apoptogenic factors from the mitochondria and inactivating the caspase death cascades. Consistent with this idea, our results showed that active caspase-3, a terminator caspase implicated in the execution step of apoptosis, was decreased by MgSO 4 treatment in the ischemic cortex. These results suggest that MgSO 4 treatment provides protection by shifting the Bcl-2 family balance toward antiapoptotic effects to block the activation of caspase 3. Consistent with our findings, previous studies have shown that MgSO 4 reduced the number of apoptotic neurons and the activation of caspase-3 in a moderate diffuse axonal injury model and in perinatal hypoxic-ischemic brain injury models (27, 30, 35) .
In summary, this study showed that the ERK-CREB-Bcl-2 signaling pathway might be involved in MgSO 4 -induced neuroprotection following focal cerebral ischemia. Additionally, MgSO 4 treatment also decreased the expression of proapoptotic proteins Bax, Bad, BNIP3 and the activation of caspase 3. The findings from the present study suggest that MgSO 4 protects neurons from apoptotic death by regulating the activity of specific cell survival and death pathways and that interference with these signaling pathways may lead to neuroprotection.
